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Arc requires PSD95 for assembly into postsynaptic complexes 
involved with brain disease and intelligence 
Proteomic and genetic dissection of Arc complexes 
shows a convergent mechanism for mental disorders 
and intelligence. 
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SUMMARY 
Arc is an activity regulated neuronal protein yet little is known about its protein 
interactions, assembly into multiprotein complexes, role in human disease and cognition. 
We applied an integrated proteomic and genetic strategy using targeted tagging of a 
Tandem Affinity Purification (TAP) tag and Venus fluorescent protein into the endogenous 
Arc gene in mice, biochemical and proteomic characterization of native complexes in wild 
type and knockout mice, and human genetic analyses of disease and intelligence. TAP 
tagging enabled efficient purification of complexes and identification of many novel Arc-
interacting proteins, of which PSD95 was the most abundant. PSD95 was essential for 
Arc assembly into 1.5 MDa complexes and activity-dependent recruitment to excitatory 
synapses. Integrating human genetic data with proteomic data showed postsynaptic Arc-
PSD95 complexes are enriched in schizophrenia, intellectual disability, autism and 
epilepsy mutations and normal variants in intelligence. Arc-PSD95 postsynaptic 
complexes are a target for normal and pathological genetic variants impacting on human 
cognitive function.Arc-PSD95 postsynaptic complexes are a molecular substrate for the 
convergence of normal and pathological genetic variants impacting on human cognitive 
function. 
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INTRODUCTION 
Arc/Arg3.1 was originally identified as a cytoskeletal protein encoded by an mRNA that 
was rapidly transcribed following synaptic activity and transported to dendrites (Link et 
al., 1995; Lyford et al., 1995; Moga et al., 2004; Steward et al., 1998). Many forms of 
neuronal activation induce Arc: synaptic stimulation including long-term potentiation 
(Guzowski et al., 2000), metabotropic glutamate receptor-dependent long-term 
depression, (Jakkamsetti et al., 2013; Park et al., 2008; Waung et al., 2008), homeostatic 
scaling of AMPA receptors (Gao et al., 2010; Korb et al., 2013; Okuno et al., 2012; 
Shepherd et al., 2006), generalized neuronal activity induced by seizures (Link et al., 
1995) as well as various behavioral stimuli (memory- and experience-related behavioral 
patterns) (Daberkow et al., 2007; Gao et al., 2010; Guzowski et al., 1999; Jakkamsetti et 
al., 2013; Kelly and Deadwyler, 2003; Miyashita et al., 2009; Vazdarjanova and Guzowski, 
2004; Vazdarjanova et al., 2006; Wibrand et al., 2012), and visual stimuli (Wang et al., 
2006). Knockout or knockdown of Arc results in impaired synaptic plasticity and 
hippocampus-dependent learning and behavior phenotypes reminiscent of schizophrenia  
(Guzowski et al., 2000; Manago et al., 2016; McCurry et al., 2010; Plath et al., 2006; 
Wang et al., 2006).  
 
Arc is mainly localized at postsynaptic sites of excitatory synapses (Moga et al., 2004). 
The proteome of the postsynaptic terminal of excitatory synapses of vertebrate species 
contains a highly conserved set of ~1000 protein types (Bayes et al., 2012; Bayes et al., 
2017; Bayes et al., 2011b; Distler et al., 2014) organized into >200 multiprotein complexes 
(Frank and Grant, 2017; Frank et al., 2016; Frank et al., 2017b). The multiprotein 
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complexes are organized into a hierarchy of complexes and supercomplexes (complexes 
of complexes) and the prototype supercomplex is formed by PSD95 (Fernandez et al., 
2009; Frank et al., 2016; Frank et al., 2017b; Husi and Grant, 2001; Husi et al., 2000). 
Arc was found to be associated with PSD95 (Fernandez et al., 2009; Frank et al., 2016; 
Frank et al., 2017a; Husi et al., 2000) and genetic studies show that absence of either 
PSD95 or Arc leads to enhanced Long-Term Potentiation (LTP) and impaired 
hippocampus-dependent learning (Migaud et al., 1998; Plath et al., 2006). Biochemical 
purification and mouse genetic experiments show dimers of PSD95 assemble with 
multiple complexes including NMDA receptors, potassium channels, signaling and 
adhesion proteins. These are not all found within a single supercomplex, but are within 
an extended family of PSD95 supercomplexes ranging in size from 1–3 MDa (Frank and 
Grant, 2017; Frank et al., 2016; Frank et al., 2017b). A large-scale mouse genetic screen 
of >50 postsynaptic proteins found that PSD95 and its close interacting proteins had the 
strongest phenotypes in synaptic electrophysiology and behavior, indicating that PSD95 
supercomplexes are crucial components of the postsynaptic terminal of excitatory 
synapses (Komiyama et al., submitted; Kopanitsa et al., submitted). Arc has also been 
proposed to interact with the endocytic machinery (Dynamin, Endophilin-2 and -3) 
(Chowdhury et al., 2006; Rial Verde et al., 2006; Shepherd et al., 2006). However, Arc 
multiprotein complexes have not been purified and systematically studied using proteomic 
mass spectrometry and thus the identify of its interacting partners and composition of Arc 
complexes remains poorly understood. 
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Characterizing protein complexes in synapses is technically challenging and the use of 
gene-tagging of endogenous proteins in the mouse has greatly facilitated purification of 
intact native complexes and visualization of their subcellular localization, and has many 
advantages over in vitro and recombinant methods (Broadhead et al., 2016; Fernandez 
et al., 2009; Frank and Grant, 2017; Frank et al., 2016). The effect of mutations on 
complexes and neuronal activation can be combined in mice carrying knockin gene tags, 
and proteins that are predicted to be largely unstructured and form multivalent 
interactions, such as Arc (Xue et al., 2010), can be studied in their native context. These 
advantages have been illustrated by the purification of native NMDA receptor and PSD95 
complexes, where a Tandem-Affinity Purification (TAP) tag was inserted into the N-
terminus of the GluN1 subunit and C-terminus of PSD95 by genome engineering 
(Fernandez et al., 2009; Frank et al., 2016). Purification revealed NMDA receptors and 
PSD95 were in ~1.5 MDa supercomplexes with channel subunits, PSD95 and PSD93 as 
major components. Genetic dissection in vivo using mutant mice showed an essential 
tripartite requirement for PSD95, PSD93 and the GluN2B cytoplasmic domain (Frank et 
al., 2016).  This tripartite interaction was not previously detected using in vitro methods 
which typically rely on binary protein interactions. Moreover, like Arc, the GluN2B 
cytoplasmic domain is predicted to be a structurally unfolded/disordered domain (Ryan et 
al., 2008), and these domains lack stable tertiary structure, and undergo disorder-to-order 
transitions upon binding or changes in phosphorylation (Bah et al., 2015; Gibbs et al., 
2017). We therefore considered that Arc was well suited to the strategy of gene tagging 
and genetic dissection.  
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Genetics has been a powerful approach for studying the function of multiprotein 
complexes in many prokaryotic, eukaryotic and metazoan organisms, including humans, 
where disease-causing mutations have been mapped to protein complexes (Babu et al., 
2014; Lu et al., 2013; Vidal et al., 2011). Moreover, in recent years, a large number of 
mutations that disrupt postsynaptic proteins in humans have been identified and found to 
cause many psychiatric, neurological and developmental disorders (Bayes et al., 2014; 
Bayes et al., 2011a; Brose et al., 2010; Fromer et al., 2014; Grant, 2012; Grant et al., 
2005; Grant, 2013; Kirov et al., 2012; Pocklington et al., 2006; Purcell et al., 2014). 
Although mutations in the human ARC gene have not been directly linked to any mental 
disorder, using preliminary proteomic data on Arc interacting proteins, the proteins in Arc 
complexes were found to be enriched in disruptive mutations (Purcell et al., 2014), de 
novo copy-number variants (CNVs) (Kirov et al., 2012), non-synonymous de novo single 
nucleotide variants (SNVs) and small insertions and deletions (indels) (Fromer et al., 
2014) in schizophrenia cases. ARC protein has been described to accumulate at 
synapses in Angelman syndrome (Greer et al., 2010) and increased and/or decreased in 
several animal models of Alzheimer’s disease and patient-derived cells (for review see 
(Kerrigan and Randall, 2013). These data suggest that Arc is a component of protein 
complexes that are involved with human cognitive disorders. 
 
In this paper, we have conducted an extensive proteomic and genetic dissection of Arc 
protein complexes, which is a generic strategy suitable for the characterization of 
potentially any synaptic protein. We have focused on the following four challenges: i) the 
isolation of native multiprotein complexes from brain tissue, ii) the visualization of the 
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endogenous protein using genetic tagging, iii) genetic dissection of protein complex 
organization and localization using mouse genetic models, iv) genetic dissection of 
complexes using human genetic data including human disease and cognitive phenotypes. 
Here we demonstrate that this integrated proteomic and genetic strategy reveals 
important new insights into Arc’s role in biology and the synaptic basis of mental disorders 
and intelligence.  
 
RESULTS 
TAP tagging and proteomic analysis of endogenous Arc complexes 
To label and isolate endogenous Arc protein we engineered knockin mice (ArcTAP) 
harboring a Tandem Affinity Purification (TAP) tag fused to Arc’s carboxyl terminus 
(Figure 1A; Figures S1, S2). Mice carrying the TAP tag showed no detectable alterations 
in levels or localization of Arc in the brain or in hippocampal synaptic physiology (Figure 
S3 and S4). Native Arc complexes were detected by immunoblotting of brain extracts 
separated on blue-native PAGE (BNP), which showed a major band of median mass ~1.5 
MDa with several additional minor species ranging from ~200-700 kDa (Figure 1B).  
 
The TAP tag was used to isolate Arc complexes directly from mouse forebrain tissue 
using a highly efficient purification protocol (recovering >70% Arc) (Figure 1C,D) and their 
composition determined using LC-MS/MS. The single-step purification yielded 102 high-
confidence proteins whereas the more stringent tandem-purification protocol recovered a 
subset of 39 proteins (34/39 were uncovered by the single-step purification)(Experimental 
procedures, Table S1) (http://www.genes2cognition.org/publications/tap-arc). Eight out of 
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14 previously reported Arc interactors were found among the 107 high-confidence 
proteins indicating that 99 were novel interactors (Table S2). Among the 107 high-
confidence proteins, 72 proteins contain the Arc-N lobe consensus motif 
P[STVILMKR][FYH] (Zhang et al., 2015) revealing a strong network of direct interactors  
(Table S1). Comparison of mouse and human show 87% (92/107) of Arc interacting 
proteins were conserved between species (Table S3), 70% (1012 in human of 1447 in 
mice) of protein-protein interactions were conserved (Table S4) and the Arc interactome 
was enriched (72%) in proteins in the human postsynaptic complexes found in Bayes et 
al., (2012) (Table S4). Together these results suggest we have defined a robust Arc 
complex and interactome that is highly conserved between mouse and human. 
 
PSD95 was the most abundant Arc interacting protein: using iBAQ quantification 
(Schwanhausser et al., 2011) of the single-step purification it showed ~1:1 stoichiometry 
with Arc (Figure 1E, Table S5) and in the tandem-purification it represented 57% of the 
Arc interactome (Table S6). Reciprocal immunoprecipitations show PSD95 assembles 
into Arc complexes from early developmental stages (P11) in hippocampus and cortex 
(Figure S5). The Dlg gene family of adaptor/scaffold proteins, comprising four paralogs 
(SAP97/Dlg1, PSD93/Dlg2, SAP102/Dlg3, PSD95/Dlg4), was the most abundant of 
eleven protein classes recovered, suggesting they play a principal role in regulating Arc 
function (Figure S6; Tables S7 and S8). Specificity of interaction between Arc and specific 
Dlg paralogs was suggested by the finding that PSD93 and SAP97 were also highly 
abundant, whereas SAP102 was not detected in the Arc interactome (confirmed using 
reciprocal immunoprecipitation, Figure S7). Forty nine percent of Arc interacting proteins 
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were known PSD95 interactors and particularly enriched in membrane proteins including 
NMDA and AMPA receptors (Table S1). 
 
Consistent with their coassembly with Arc, the NMDA receptor, PSD95 and PSD93 were 
also shown to reside in 1.5 MDa supercomplexes (Frank et al., 2016). To compare the 
relative abundance of Arc and PSD95 in 1.5MDa supercomplexes we immunoblotted 
ArcTAP/+ and PSD95TAP/+ brain extracts separated by BNP with Flag antibodies (Figure 
1F). PSD95 was ~20 fold more abundant than Arc indicating ~5% of PSD95 complexes 
contain Arc. Pull down of PSD95 complexes using the TAP tag recovered 65% of PSD95 
and depleted 37% of Arc, indicating that ~58% of Arc is in PSD95 supercomplexes (data 
not shown). Together, these data indicate that PSD95 is the major interacting protein of 
Arc and that a subset of the postsynaptic 1.5 MDa PSD95 supercomplexes contain Arc. 
 
Arc postsynaptic localization requires PSD95 
How Arc is localized to the postsynaptic terminal is unknown. To address this question 
we asked if members of the Dlg scaffold proteins were required in vivo, using mice 
carrying knockout mutations. In hippocampal extracts from PSD95, PSD93 and SAP102 
knockout mice (SAP97 knockout mice are unviable) we found that Arc protein levels were 
reduced (35.0 ± 17.1% of WT; p < 0.01) in PSD95 knockout mice but not in either PSD93 
or SAP102 knockout mice (Figure 2A and Figure S8). A dramatic loss of dendritic staining 
of TAP tagged Arc was observed in hippocampal sections from PSD95 knockout mice 
(Figure 2B). Furthermore, synaptosomes from PSD95 knockout mice also showed a 
major reduction in Arc (Figure 2C). We also examined BNP immunoblots from PSD95 
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knockouts and found that 1.5 MDa Arc complexes were severely diminished, with a weak 
residual signal after long exposure of the gel (Figure 2D). Thus, PSD95 is specifically 
required to localize Arc to the postsynaptic terminal. 
 
To visualize endogenous Arc protein we created ArcVenus knockin mice, using a similar 
design strategy to the ArcTAP mice, where the Venus fluorescent protein was fused to the 
C-terminus of Arc (Figure S1B). Mice carrying the Venus tag showed no detectable 
alterations in hippocampal synaptic physiology (Figure S9). We bred Arc-Venus mice with 
PSD95 knockouts to generate compound transgenic mice (ArcVenusxPSD95-/-) and asked 
if kainic acid induced neuronal activity (Li et al., 2005) would drive Arc to the synapse and 
whether this required PSD95. In the absence of PSD95, Arc-Venus failed to localize to 
the synapse (Figure 2E). These results demonstrate that PSD95 is required for the 
postsynaptic localization of Arc into 1.5 MDa complexes in the steady state and following 
induction by neuronal activity.  
 
Proteomic analysis of Arc complexes in mice lacking PSD95 
We reasoned that by genetic removal of PSD95, we could identify those Arc interacting 
proteins that were most dependent on PSD95. We bred ArcTAP/TAP with PSD95 knockout 
mice (ArcTAP/TAP/PSD95-/-) mice and analyzed their Arc interactome using quantitative 
proteomic methods (Figure 3A; Figure S10 and Table S9). As shown in Figure 3A, Arc 
interacting proteins separated into two broad subgroups: depleted and enriched proteins 
(see red and green proteins respectively). Seventy percent of depleted proteins were 
PSD95 interacting proteins, including PSD93. As shown by immunoblots of BNPs, PSD93 
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remained in 1.5 MDa complexes in PSD95-/- mice (Figure 2D and (Frank et al., 2016). 
Absence of PSD93 did not affect the interaction of Arc with PSD95 (Figure S11). The 
most significant GO Biological Process (BP) terms in the depleted proteome are synaptic 
transmission (p-value=1.23x10-11), cell-cell signaling (p-value=3.94x10-9), and 
modulation of synaptic transmission (p-value=1.35x10-7) highlighting the functional 
importance of the depleted proteins (Table S8).  
 
Amongst the 12 most enriched proteins in the Arc complexes isolated from PSD95 mutant 
mice were SAP97 and structural proteins including those with a potential role in cell 
growth and adhesion (Claudin11, Lgi1). A network graph of the interactions of the 
enriched and depleted proteins sets is shown in Figure 3B. The internal network consists 
of 26 proteins and 44 interactions (visualised using Visone, (Brandes, 2012). Taken 
together these proteomic and in vivo genetic studies show that Arc is tethered to 
postsynaptic 1.5 MDa signaling complexes containing PSD95 and when these complexes 
are abolished in PSD95 mutants, Arc is found associated with cytoskeletal and structural-
related proteins. Thus, Arc is partitioned into either the PSD95 supercomplexes in the 
postsynaptic terminal or into cytoskeletal complexes. 
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Arc complexes in disease 
Proteins within the postsynaptic proteome are assembled into complexes and 
supercomplexes (Frank et al., 2016) and this supramolecular organization is of crucial 
importance in human genetic disorders since it is a mechanism by which the many 
different gene products functionally converge. We therefore combined our proteomic 
datasets with human genetic datasets to understand the importance of Arc interacting 
proteins in human disease. 
 
Preliminary proteomic data from ArcTAP mice has previously been used to implicate the 
disruption of ARC complexes in human psychiatric disorders. The first such study 
revealed that components of Arc complexes were enriched in de novo CNVs from 
individuals with schizophrenia (Kirov et al., 2012), with subsequent studies finding 
enrichment for rare point mutations in individuals with schizophrenia, autism and 
intellectual disability (ID) (Fromer et al., 2014; Kirov et al., 2012; Purcell et al., 2014). Here 
we extend this analysis using complete sets of Arc interacting proteins and additional 
genetic datasets including epilepsy and healthy control de novo datasets. 
 
We first sought to replicate the initial finding of (Kirov et al., 2012) with the comprehensive 
Arc interactome. Utilizing the same genetic dataset as (Kirov et al., 2012) we found that 
de novo CNVs from schizophrenia probands were enriched for Arc complex genes 
compared to de novo CNVs from unaffected individuals (P = 0.0047). Arc interactors 
whose association with Arc is depleted in PSD95 knockout mice largely drove this 
enrichment (P = 0.0165), indicating the importance of the postsynaptic 1.5 MDa 
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complexes. We next investigated enrichment of the Arc interactome for rare point 
mutations and indels contributing to brain disorders, using exome sequencing data from 
a case/control schizophrenia study (Purcell et al., 2014) and de novo studies performed 
in cohorts of schizophrenia, autism, intellectual disability and epilepsy (see Supplemental 
Experimental Procedures).  Combining evidence from each of these independent 
datasets we found strong support for the enrichment of both nonsynonymous (NS) and 
loss-of-function (LoF) disease-related mutations amongst Arc interactors (P = 9.01 x 10-
12
 and 2.051 x 10-7 respectively, Table 1). All 5 datasets contributed to this enrichment 
(Table 1, Table S10 and Table S11), indicating that disruption of Arc complexes may 
contribute to a wide range of brain disorders. Consistent with the analysis of de novo 
CNVs, much of the enrichment in LoF and NS mutations was attributable to Arc 
interactors whose expression is altered in the PSD95-/- mouse. This suggests that it is 
postsynaptic Arc-PSD95 complexes and not cytoplasmic Arc complexes that are relevant 
to these disorders.  
 
Arc complexes in normal variation in human intelligence 
Although the role in cognition for Arc, PSD95 and their interacting proteins is well 
established from studies of mutations in mice (Fernandez et al., 2009; Fitzgerald et al., 
2014; Husi et al., 2000; Komiyama et al., 2002; McCurry et al., 2010; Migaud et al., 1998; 
Nithianantharajah et al., 2013; Plath et al., 2006; Ryan et al., 2013), and mutations in 
humans cause cognitive disorders, and enrichment analysis of Arc interacting proteins 
for Mammalian Phenotype (MP) terms shows 48 enriched terms (P < 0.01) associated 
with abnormal synaptic and cognitive functions (Table S12), much less is known about 
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the relevance to normal variation in human cognition. We therefore asked whether 
common genetic variation in Arc complexes was associated with common variation in 
general cognitive ability (known as intelligence or g) using the genome-wide association 
study (GWAS) on intelligence from the five cohorts (n = 3511) that make up the Cognitive 
Ageing in England and Scotland (CAGES) consortium (Davies et al., 2011; Hill et al., 
2014a). The five cohorts are the Lothian Birth Cohort of 1921 and 1936 (Deary et al., 
2012), the Aberdeen Birth Cohort of 1936 (Whalley et al., 2011), and the Manchester and 
Newcastle Longitudinal Studies of Cognitive Ageing (Rabbitt et al., 2004), which together 
consist of a total of 3511 healthy middle to old aged individuals who all live independently 
in the community. The measure of general cognitive ability was taken from the GWAS 
previously conducted by (Hill et al., 2014a) (Supplemental Experimental Procedures). In 
order to determine if there was a greater weight of evidence for association between the 
Arc gene set and general cognitive ability a two-stage enrichment test was used. Firstly, 
single nucleotide polymorphisms (SNPs) were assigned to autosomal genes and a gene 
based statistic was derived (Liu et al., 2010a). Secondly, the p-values of the gene based 
statistics were –log(10) transformed before Gene Set Enrichment Analysis (GSEA) 
(Subramanian et al., 2005), a competitive test of enrichment was used Gene Set 
Enrichment Analysis (GSEA) (Subramanian et al., 2005). The results of the gene based 
analysis are shown in Table S13 where eight genes were nominally significant in CAGES 
and nine in BATS (the Brisbane Adolescent Twin Study) (BATS). The most significant 
gene in the BATS cohort (PRRT1, P = 0.00732) was also nominally significant in CAGES, 
P = 0.03797. The results of the enrichment analysis show that common genetic variation 
in Arc complex proteins show nominally significant association (P = 0.0473) with 
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intelligence compared with control gene sets. A replication study using the summary data 
of a GWAS conducted on intelligence (Hill et al., 2014a) the BATS (n = 2062) (de 
Zubicaray et al., 2008; Wright et al., 2001; Wright and Martin, 2004) also showed a 
significant enrichment (P = 0.0247) confirming the results found in the CAGES 
consortium. This significant enrichment shows that common genetic variation in the genes 
encoding Arc complex proteins is associated with the normal variation in human 
intelligence differences.  
DISCUSSION  
We have developed and demonstrated an integrated proteomic and genetic strategy that 
reveals important new insights into Arc’s role in biology, the synaptic basis of mental 
disorders and intelligence. Multiple genetic and genome engineering methods were 
combined to isolate native Arc complexes, identify their constituents, determine the 
mechanism of assembly and localization to the postsynaptic terminal, and identify multiple 
diseases and mutations that converge on the complexes.  
 
Arc protein is principally housed within 1.5 MDa complexes and proteomic mass 
spectrometry identified many novel Arc interacting proteins of which PSD95 was the most 
abundant. PSD95 and Arc coassemble into 1.5 MDa supercomplexes and knockout of 
PSD95 abolishes these complexes and severely depletes Arc from the postsynaptic 
terminal and prevents its activity-dependent recruitment. The combined use of gene-
tagged and mutant mice allowed us to dissect the interactions of Arc with specific subsets 
of postsynaptic complexes. PSD95 supercomplexes are a family from which ~3% contain 
NMDA receptors (Frank et al., 2017b). The NMDA receptor requires PSD93 for 
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coassembly with PSD95 (Frank et al., 2016) and in the present study we found that 
PSD93 knockouts did not interfere with Arc-PSD95 interactions. Therefore, Arc can 
assemble with PSD95 supercomplexes that do not contain NMDA receptors. We also 
found that Arc did not interact with SAP102, which forms distinct complexes at ~350 kDa 
(Frank et al., 2016), nor did Arc require SAP102 for postsynaptic targeting. Together 
these results demonstrate that Arc is targeted to the postsynaptic terminal where it 
selectively interacts with signaling complexes organized by PSD95. Super-resolution 
microscopy has revealed that PSD95 and SAP102 are in separate nanodomains (Zheng 
et al., 2011) within the dendritic spine and that PSD95 nanodomains (Broadhead et al., 
2016; Fukata et al., 2013; Nair et al., 2013) are positioned beneath the presynaptic 
release machinery (Tang et al., 2016). This suggests that Arc is selectively targeted by 
PSD95 to this critical region of the postsynaptic terminal where its supercomplexes 
participate in controlling synaptic transmission and plasticity. 
 
Disruption of many proteins in Arc, PSD and many other proteins in the supercomplexes, 
lead to changes in synaptic plasticity and behavior, including knockout of Arc and PSD95 
which both lead to enhanced LTP and impaired learning (Carlisle et al., 2008; Komiyama, 
submitted; Kopanitsa, submitted; Migaud et al., 1998; Nithianantharajah et al., 2013; Plath 
et al., 2006). A recent large-scale genetic screen of postsynaptic proteins in mice showed 
PSD95 supercomplexes were essential for the postsynaptic responses to simple and 
complex patterns of activity and the modulation of synaptic strength over a range of 
milliseconds to an hour (Kopanitsa et al., submitted). The supercomplexes were also 
essential for tuning the magnitude of innate and learned behavioral responses, including 
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simple and complex forms of behavior (Komiyama et al., submitted). Furthermore, these 
studies show that each innate and learned behavioral response required a specific subset 
or combination of postsynaptic proteins, which suggests that transient up-regulation and 
targeting of Arc to PSD95 supercomplexes will transiently modify behavior and synaptic 
physiology. This mechanism is consistent with the known role of Arc in learning. 
 
The proteomes of the PSD and PSD95 supercomplexes are highly conserved between 
mice and humans (Bayes et al., 2011a) and specific genes (e.g. PSD93) have conserved 
roles in cognition (visuo-spatial learning, cognitive flexibility and attention) 
(Nithianantharajah et al., 2013). Our finding that human genetic disorders of cognition 
converge on Arc-PSD95 supercomplexes is in agreement with the mouse genetic 
findings. Here, wWe have reaffirmed the role of the supercomplexes in schizophrenia and 
extended the study to autism and intellectual disability. Moreover, the finding that variation 
in normal human intelligence and disorders of cognition involves the same sets of proteins 
indicates that genetic variation in Arc-PSD95 supercomplexes underpins the phenotypic 
continuum between normal cognitive variation and pathology.  
 
There are over 130 brain diseases linked to mutations in the postsynaptic proteome 
(Bayes et al., 2011a) and a large number of uncharacterized multiprotein complexes 
(Frank et al., 2016), many of which contain at least one protein encoded by a disease 
gene. The integrated workflow shown here which is centered on genetically tagged mice 
and proteomic approaches offers a general and scalable approach toward understanding 
how the polygenic basis of brain disease is linked to the supramolecular organization of 
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proteins in the postsynaptic terminal of central synapses. All datasets are freely available 
through the Genes to Cognition website (www.genes2cognition.org).  
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EXPERIMENTAL PROCEDURES 
Materials 
Antibodies and reagents are detailed in Supplemental Experimental Procedures. 
 
Animals 
Arc transgenic mice (ArcTAP and Arc-Venus), PSD95 knockout mice (PSD95-/-) and the 
strains ArcTAP and Arc-Venus crossed with PSD95-/- (ArcTAPxPSD95-/-, ArcVenusxPSD95-/-) 
used for experimental analysis were 2- to 5-month-old males from several intercrosses 
between the chimeras and C57BL/6 strain mice. Males were only used for experimental 
purposes. All animal experiments were conducted in a licensed animal facility in 
accordance to guidelines determined by the UK Animals (Scientific Procedures) Act, 1986 
and all procedures were approved through the British Home Office Inspectorate. Animals 
were born and housed at the Wellcome Trust Sanger Institute, and exposed to 
conventional 12:12h light/dark cycles and ad libitum food supply. Mice were sacrificed by 
cervical dislocation and the forebrain was dissected on ice and snap-frozen in liquid 
nitrogen. Brain samples were stored at -80 ºC for few weeks prior to use. 
See Supplemental Experimental Procedures for TAP and Venus Arc vector construction, 
gene targeting strategy and transgenic mice generation.  
 
Tandem Affinity Purification 
Tandem Affinity Purification (TAP) was perfomed as in (Fernandez et al., 2009). Briefly, 
mouse forebrain was homogenized on ice in 1% DOC buffer (50 mM Tris pH9.0, 1% 
Sodium Deoxycholate, 50 mM NaF, 20M ZnCl2, 1mM Na3VO4), 2 mM Pefabloc SC 
  21 
(Roche) and 1 tablet/10ml protease inhibitor cocktail tablets (Roche) at 0.38 g wet weight 
per 7 ml cold buffer with a glass Teflon Douncer homogenizer. The homogenate was 
incubated for 1h at 4ºC and clarified at 50,000 g for 30 min at 4ºC. Isolation of Arc TAP 
tagged complexes was performed as described (Fernandez et al., 2009). The gel was 
fixed, stained with Colloidal Coomassie and lanes were cut into slices, destained and 
digested overnight with trypsin (Roche, Trypsin modified, sequencing grade) as described 
previously (Fernandez et al., 2009). Peptide digestion, LC-MS/MS, and proteomics data 
analysis is extensively described in Supplemental Experimental Procedures.  
 
Blue Native PAGE 
Blue-native PAGE has been performed as described in (Frank et al., 2016). See 
Supplemental Experimental Procedures for further description.  
 
Cellular fractionation 
Brain cellular fractionation was done according to the protocol described earlier 
(Chowdhury et al., 2006). See Supplemental Experimental Procedures for details.  
 
Electrophysiology in hippocampal slices 
Field excitatory postsynaptic potentials (fEPSPs) in the CA1 area of acute hippocampal 
slices were recorded using multi-electrode arrays as previously described (Coba et al., 
2012; Kopanitsa et al., 2006). See Supplemental Experimental Procedures for detailed 
protocol.  
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Enrichment analysis of CNVs and rare coding mutations in Arc interactors in 
human neuropsychiatric disease. 
In order to map rodent proteins onto human genes, all of the majority protein ids from 
Table S1 were first converted into both MGI & mouse NCBI/Entrez gene ids using the 
online ID mapping tool provided by Uniprot. These gene ids were then converted to 
human Entrez ids using the mapping file 'HOM_MouseHumanSequence.rpt', available 
from MGI (http://www.informatics.jax.org/). Any genes with a non-unique (e.g. 1-many) 
mapping between species, or where MGI and mouse Entrez ids mapped to different 
human genes, were excluded. De novo CNV enrichment analysis and de novo mutation 
exome sequencing datasets are detailed in Supplemental Experimental Procedures.  
 
For the analysis of de novo mutations, we used DNENRICH, a freely-available software 
previously described (Fromer et al., 2014) (https://psychgen.u.hpc.mssm.edu/dnenrich/). 
Briefly, DNENRICH estimates the observed number of de novo mutations per gene or 
geneset by a genomic permutation strategy, which controls for gene size and structure, 
sequence coverage and local trinucleotide mutation rate.  Significance of the enrichment 
in the rate and recurrence of mutations was assessed empirically by permutation.  For 
the case/control data, we used the SMP algorithm (Purcell et al., 2014) which is part of 
the PLINK/Seq package (http://atgu.mgh.harvard.edu/plinkseq/). Briefly, the test for 
enrichment of a set of genes is based on the sum of gene-level case/control burden 
statistics relative to the exome-wide excess of burden in cases.  Significance is assessed 
by permutation, comparing the observed distribution against 10,000 null replicates 
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(created by shuffling case/control labels within groups matched for ancestry and technical 
variables). 
 
Neuropsychiatric genetic analyses: multiple testing correction 
We first sought to verify the initial finding of Arc complex enrichment in de novo CNVs 
that has formed the foundation for all subsequent studies; this we correct for the 4 Arc 
complex gene-sets tested. We then turned to the analysis of rare coding variants. While 
there is consistent evidence for disease-variant enrichment across multiple independent 
studies (based on preliminary Arc data), these associations are modest. We therefore 
combine enrichment p-values from each rare-variant dataset to provide an overall 
summary of the evidence. These summary p-values are corrected for 12 tests: 4 Arc 
complex gene-sets tested x 2 classes of mutation (LoF and NS), plus the 4 de novo CNV 
tests already performed. This correction is likely to be conservative, as LoF and NS 
mutations are not independent sets. Finally, we present enrichment p-values for individual 
datasets, correcting for 52 tests (4 Arc complex gene-sets x LoF and NS mutations x 5 
individual datasets, plus the 12 tests already performed). 
 
Human cognitive ability phenotype and analysis 
The phenotypes used in both the Cognitive Ageing in England and Scotland (CAGES) 
and the Brisbane Adolescent Twin Study (BATS) samples were taken from the summary 
data of (Hill et al., 2014a) and are described in Supplemental Experimental Procedures. 
Genome wide association had been carried out in each cohort of CAGES using 
Mach2QTL (Li et al., 2010) before being meta-analysed in METAL (Willer et al., 2010) 
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using an inverse variance weighted model. SNPs were then assigned to genes based on 
their position in the UCSC human genome browser hg 18 assembly with a 50kb boundary 
around each gene to capture any regulatory elements. A gene based statistic was derived 
using VEGAS (Liu et al., 2010b) to control for the number of SNPs assigned to each gene 
as well as patterns of linkage disequilibrium. In order to test the principal hypothesis that 
the genes of the Arc complex (See Table S13) will show a greater association, as a set, 
than those drawn from across the genome, each gene based p value was –log10 
transformed and rank ordered. Gene Set Enrichment Analysis (GSEA) (Subramanian et 
al., 2005; Wang et al., 2007), a competitive test of enrichment, was then used to 
determine if the gene identifiers for the Arc gene set fall higher in the genome-wide 
rankings than would be expected by chance alone (Hill et al., 2014a; Hill et al., 2014b). 
This was done for each set by deriving a Kolmogorov-Smirnov (K-S) statistic weighted by 
the p-values of the gene based statistic in order to take into account both the ranks and 
the distance between ranks. Following this the genome wide ranked set was permuted 
and the K-S statistic calculated again. Statistical significance was established by using 
15,000 permutations of the genome wide ranked set with the p-value describing the 
proportion of permuted K-S tests smaller than the original un-permuted K-S statistic. 
Statistical significance was set at < 0.05 and FDR <0.25 (Subramanian et al., 2005; Wang 
et al., 2007). 
 
 
Immunostaining of brain sections and primary neurons, forebrain extracts and 
western blot, PSD95 immunoprecipitation, classification of Arc interactors 
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according to their gene ontology process, creation of Arc interactor genesets, 
network building and statistics are described in Supplemental Experimental 
Procedures. 
 
SUPPLEMENTAL INFORMATION 
Supplemental information includes Supplemental Experimental Procedures, 11 figures, 
14 tables, Supplemental Figures and Table legends and Supplemental References.  
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FIGURES AND TABLE LEGENDS 
Figure 1. Tandem Affinity Purification of Arc reveals postsynaptic complexes with 
a native size of 1.5 MDa. (A) Structure of the TAP tagged Arc regions including a 
potential coiled coil domain, a SH3-endophilin-2 and -3 binding region, a dynamin-2 
binding region and the C-terminal TAP tag sequence domain before the stop codon of the 
protein. (B) BNP of wild type and ArcTAP/+ forebrain extracts blotted with Flag and Arc 
antibodies where Arc and TAP tagged Arc can be mainly detected at 1.5 megadalton 
(MDa). Closed arrow indicates the main Arc complex whereas open arrows indicate lower 
molecular weight Arc complexes. (C) Arc was tandem affinity purified from ArcTAP/TAP 
forebrain extracts, eluted and collected in 5 consecutive fractions following HAT 
purification. (D) Colloidal Coomassie staining of three independent tandem affinity 
purifications from wild type (left) and ArcTAP/TAP (right) forebrains. The lanes were cut for 
LC-MS/MS and the identified proteins are listed in Table S1. Arc and the Tev enzyme are 
indicated. (E) The absolute expression value of each protein in the tandem purification 
was estimated by the iBAQ intensity values obtained in each purification. (F) BNP of wild 
type, ArcTAP/+ and PSD95TAP/+ forebrain extracts blotted with Flag antibody. TAP tagged 
Arc and TAP tagged PSD95 levels are detected. WT, wild type; TAP/+, heterozygous for 
TAP tagged Arc or PSD95 as indicated; SN: supernatant; Mw: molecular weight; MDa: 
megadalton; kDa: kilodalton. 
 
Figure 2. Arc protein levels are reduced in fractions of PSD95 knockout mice. (A) 
Representative immunoblot showing relative abundance of PSD95, Arc, GluR1 and 
GluR2 proteins in total hippocampal lysates from PSD95 knockout (PSD95-/-)  and 
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matched WT littermates. Arc is reduced to 35.0 ± 17.1% of the wild type in the PSD95 
mutant mice (N=4 for each matched pair *P<0.05). nNOS was used as loading control. 
(B) Representative Arc staining of sagittal sections of hippocampus (left panels) and 
magnification of the granular layer (right panels) for wild type and PSD95 knockout mice. 
DG: Dentate gyrus. Bar = 1mm. (C) Hippocampal extracts of PSD95 mutant and WT 
mutant mice were biochemically fractionated into synaptosomes and into cytoskeletal and 
vesicular components, referred to as “Light”.  The synaptosomal fraction was 
subsequently dissociated into PSDs and Triton X-100 soluble fraction. Arc levels were 
dramatically reduced in the PSD95 mutant while no changes in GluR1, GluN2B, IRSp53 
and Rac1 proteins were observed. (D) BNP of WT and PSD95 knockout forebrain extracts 
blotted with Arc and PSD95 antibodies. Long exposure of the blots shows Arc complexes 
migrating at a lower molecular weight than 1.20 MDa (middle panel). (E) Representative 
section of ArcVenus brain crossed with WT (left panel) and PSD95-/- (right panel) mice. Bar 
chart of the total cell fluorescence corrected by the area and the background signal. Bar 
= 15 m.  WT: wild type; PSD95-/-: PSD95 knockout mice; SN: Triton X-100 soluble 
fraction. Mw: molecular weight; MDa: megadalton; kDa: kilodalton. BNP: Blue Native 
PAGE.  
 
Figure 3. Quantitative proteomics analysis of ArcTAP reveals a depletion of 
postsynaptic proteins in the PSD95 knockout mice. (A) Dimethyl labeling-based 
quantitative mass spectrometry of TAP purified proteins from ArcTAP/+ and ArcTAP/TAP 
crossed with PSD95 knockout forebrain (ArcTAP/TAPPSD95-/-). Plot displays enrichment 
ratios of ArcTAP/TAPPSD95-/- versus ArcTAP/+ (x axis) and iBAQ enrichment values of the 
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step purification (y axis). Proteins meeting criteria for enrichment (>1.5 fold) are 
highlighted in green and for depletion (<0.667 fold) are highlighted in red. Name of 
depleted and enriched PSD95 interactors is indicated. See Supplemental Experimental 
Procedures for enrichment criteria. (B) Mouse interactome network constructed from the 
publicly available databases BioGrid, DIP, IntAct, MINT, STRING, UniProt, BIND and 
mentha using the Psicquic software package. Network is visualised using Visone. 
Proteins highlighted green/red meet the enrichment/depletion criteria discussed in the 
Experimental procedures. 
 
Table I. Arc gene set analysis of autism, schizophrenia, epilepsy, intellectual disability 
(ID) and schizophrenia candidate gene sets. Enrichment test empirical  P values for 
autism (De Rubeis et al., 2014; Iossifov et al., 2012; Jiang et al., 2013), epilepsy (Euro et 
al., 2014), ID (de Ligt et al., 2012; Hamdan et al., 2014; Rauch et al., 2012) and 
schizophrenia (Fromer et al., 2014; Girard et al., 2011; Gulsuner et al., 2013; Kirov et al., 
2012; McCarthy et al., 2014; Xu et al., 2012). PSD95-/-: PSD95/Dlg4 knockout mice. 
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